• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, June 28, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

ACP releases paper on methods for developing evidence-based clinical policy papers

Bioengineer by Bioengineer
June 11, 2019
in Cancer
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

ACP continues to refine and enhance methodology for guidelines and guidance statements

Philadelphia, June 11, 2019 – Recommendations for the screening, diagnosis, and treatment of various diseases often differ by organization, making it difficult to know which ones to follow. To help doctors and patients understand how high-quality, evidence-based recommendations are developed and inform their decisions, the American College of Physicians (ACP) has released a paper, published in Annals of Internal Medicine, that presents ACP’s methods for developing two types of clinical policy papers relevant to internal medicine: clinical guidelines and guidance statements.

“The hallmark of ACP’s methodology is that we base our clinical guidelines and guidance statements on the best available scientific evidence,” said ACP President Robert M. McLean, MD, FACP. “It is important for physicians, other clinicians, patients, and caregivers to know that ACP uses rigorous standards to ensure the production of trustworthy, high quality, and useful clinical policy papers and recommendations.”

ACP’s methodology meets the standards of the Guidelines International Network and the National Academy of Medicine. Recent enhancements include more stringent disclosure of interest and conflict management policies; inclusion of public members (individuals who are not physicians) and their perspective; full adoption of Grading of Recommendations Assessment, Development and Evaluation (GRADE) methods; standardized reporting formats that consider value of care, patients with multiple chronic diseases, patient values and preferences, and costs; and further clarification on guidance statement methods.

Clinical guidelines are developed based on a systematic review of the available evidence. Evidence-to-decision tables following the GRADE framework serve as the roadmap for documenting decisions and evidence behind the final recommendations. ACP considers clinical benefits and harms of an intervention and variations in patient values and preferences in deliberations about recommendations for each guideline. ACP also considers costs and burden of care when assessing health care value and developing recommendations.

Guidance statements are developed on topics where several clinical guidelines issued by other organizations are available but are conflicting. The aim of ACP guidance statements is to reconcile clinical guidelines to help physicians provide evidence-based care for their patients. ACP reviews the available clinical guidelines and their evidence base, and develops subsequent guidance based on an assessment of the reported benefits, harms, costs, and patient preferences and values from the assessed guidelines and their evidence.

ACP develops its clinical policy papers through its Clinical Guidelines Committee (CGC), a multidisciplinary group of 14 members, 12 of whom are physicians representing general internal medicine and internal medicine subspecialties (e.g., geriatrics, nephrology, rheumatology, pulmonology, and hospital medicine). The CGC also includes two non-physician public members with equal standing and terms as the physician members, including voting and authorship privileges.

“The Development of Clinical Guidelines and Guidance Statements by the Clinical Guidelines Committee of the American College of Physicians” also explains in detail ACP’s disclosure of financial and intellectual interests and management of conflicts policy; the review and approval process of clinical guidelines and guidance statements to become ACP policy; how ACP publishes its clinical guidelines and guidance statements; and how the development of ACP clinical guidelines, guidance statements, and commissioned evidence reviews are financed.

###

ACP is a well-recognized name in evidence-based medicine. ACP is member of the Guidelines International Network, whose mission is to lead, strengthen, and support collaboration in guideline development, Cochrane, a global leader and resource in evidence-informed health decision-making, has officially recognized ACP as a Cochrane US Network Affiliate. To receive such a designation, Affiliates must show a proven record of supporting evidence-based practice and expertise and competencies in systematic reviewing and evidenced-informed health practice and policy.

About the American College of Physicians

The American College of Physicians is the largest medical specialty organization in the United States with members in more than 145 countries worldwide. ACP membership includes 154,000 internal medicine physicians (internists), related subspecialists, and medical students. Internal medicine physicians are specialists who apply scientific knowledge and clinical expertise to the diagnosis, treatment, and compassionate care of adults across the spectrum from health to complex illness.

Media Contact
Steve Majewski
[email protected]
http://dx.doi.org/10.7326/M18-3290

Tags: cancerCardiologyClinical TrialsEndocrinologyInternal MedicineMedicine/HealthMetabolism/Metabolic Diseases
Share12Tweet8Share2ShareShareShare2

Related Posts

Cracking the Code: How Cancer Evades Antibody-Drug Conjugates and New Strategies to Overcome Resistance

June 25, 2026

MSU Scientists Reveal Mechanism Behind Ovarian Cancer’s Chemotherapy Resistance and Strategies to Overcome It

June 25, 2026

Rare Mixed Liver Cancer Underscores Diagnostic and Therapeutic Challenges

June 25, 2026

How Socioeconomic Factors Shape Lung Cancer Screening Experiences

June 25, 2026
Please login to join discussion

POPULAR NEWS

  • Saying Goodbye to PGY-6: Pediatric Fellowship Realities

    103 shares
    Share 41 Tweet 26
  • Multi-Hospital Study Reveals Long Covid Burden Is Twice as High as Current Estimates

    92 shares
    Share 36 Tweet 23
  • Detection of EDCs in Breast Milk and Infant Urine Up to Six Months Highlights Early Exposure Risks

    77 shares
    Share 31 Tweet 19
  • New Drug Candidate Developed at McMaster Shows Potential for Treating Brain Cancer

    58 shares
    Share 23 Tweet 15

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Tracking Lanthanide-Labeled Microplastics in Plants

POSTECH Researchers Slash Cost of Reconstituted Cell-Free Systems by 95%

AI and Physics Collaborate to Design Advanced Hydrogen Storage Materials

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.

Join 82 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.